• BCR-ABL1 Mutation Analysis for Tyrosine Kinase Inhibitor Resistance
  • Beta-2 Glycoprotein 1 Antibody, IgA
  • Filaria Antibody, IgG4
  • Endomysial (EMA) Antibody, IgA
  • Apolipoprotein B, Serum
  • Varicella Zoster Virus (VZV) Antigen, DFA
  • HBB (Hemoglobin, Subunit Beta) Gene Mutation Analysis
  • Cystatin C with Estimated GFR, Serum
  • Valproic Acid, Total, Serum
  • Boron, Quantitative, Serum
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Fabry Disease (GLA) Gene Mutation Analysis
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Fabry Disease (GLA) Gene Mutation Analysis
Medical Test

Specimen Collection
Access to Fabry Disease (GLA) Gene Mutation Analysis is restricted.